[HTML][HTML] Imaging and cancer: a review
L Fass - Molecular oncology, 2008 - Elsevier
Multiple biomedical imaging techniques are used in all phases of cancer management.
Imaging forms an essential part of cancer clinical protocols and is able to furnish …
Imaging forms an essential part of cancer clinical protocols and is able to furnish …
1H MR spectroscopy of brain tumours and masses
FA Howe, KS Opstad - … : An International Journal Devoted to the …, 2003 - Wiley Online Library
Accurate diagnosis is essential for optimum management and treatment of patients with
brain tumours. Proton magnetic resonance spectroscopy (1H MRS) provides information …
brain tumours. Proton magnetic resonance spectroscopy (1H MRS) provides information …
In vivo magnetic resonance spectroscopy in cancer
RJ Gillies, DL Morse - Annu. Rev. Biomed. Eng., 2005 - annualreviews.org
▪ Abstract Magnetic resonance spectroscopy (MRS) has been used for more than two
decades to interrogate metabolite distributions in living cells and tissues. Techniques have …
decades to interrogate metabolite distributions in living cells and tissues. Techniques have …
Detection of breast malignancy: diagnostic MR protocol for improved specificity
W Huang, PR Fisher, K Dulaimy, LA Tudorica, B O'Hea… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To prospectively determine if a combined magnetic resonance (MR) protocol
that includes T1-weighted dynamic contrast agent–enhanced (DCE) MR imaging, hydrogen …
that includes T1-weighted dynamic contrast agent–enhanced (DCE) MR imaging, hydrogen …
Proton MR Spectroscopy with Choline Peak as Malignancy Marker Improves Positive Predictive Value for Breast Cancer Diagnosis: Preliminary Study1
L Bartella, EA Morris, DD Dershaw, L Liberman… - Radiology, 2006 - pubs.rsna.org
Purpose: To prospectively evaluate the diagnostic performance of magnetic resonance (MR)
spectroscopy in patients with suspicious lesions or biopsy-proved cancers at MR imaging by …
spectroscopy in patients with suspicious lesions or biopsy-proved cancers at MR imaging by …
Nonnegative matrix factorization for rapid recovery of constituent spectra in magnetic resonance chemical shift imaging of the brain
We present an algorithm for blindly recovering constituent source spectra from magnetic
resonance (MR) chemical shift imaging (CSI) of the human brain. The algorithm, which we …
resonance (MR) chemical shift imaging (CSI) of the human brain. The algorithm, which we …
Magnetic resonance for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis
INTRODUCTION: Current methods of identifying axillary node metastases in breast cancer
patients are highly accurate, but are associated with several adverse events. This review …
patients are highly accurate, but are associated with several adverse events. This review …
Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer
Standardised proton magnetic resonance spectroscopic imaging (MRSI) was initially
developed for routine in-situ clinical assessment of human brain tumours, and its use was …
developed for routine in-situ clinical assessment of human brain tumours, and its use was …
Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors
GMK Tse, HS Cheung, LM Pang… - American Journal of …, 2003 - Am Roentgen Ray Soc
OBJECTIVE. Proton MR spectroscopy is a recently described technique with high sensitivity
and specificity for differentiating breast carcinoma from benign lesions. We evaluated the …
and specificity for differentiating breast carcinoma from benign lesions. We evaluated the …
In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy
F Sardanelli, A Fausto, G Di Leo… - American journal of …, 2009 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of our study was to use the total choline-containing compound
(tCho) peak integral as a marker of malignancy in breast MR spectroscopy (MRS) …
(tCho) peak integral as a marker of malignancy in breast MR spectroscopy (MRS) …